• Je něco špatně v tomto záznamu ?

Chronic atropine administration diminishes the contribution of vasoactive intestinal polypeptide to heart rate regulation

J. Kuncová, Š. Faitová, J. Capouch, M. Štengl, J. Slavíková

. 2008 ; 57 (6) : 827-837.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10015736

Vasoactive intestinal polypeptide (VIP) is implicated in the modulation of vagal effects on the heart rate. In this study, the impact of acute and chronic atropine administration on VIP levels in rat heart atria was investigated in relation to heart rate in the course of vagus nerves stimulation. Anaesthetised control and atropinised (10 mg/kg/day for 10 days) rats pretreated with metipranolol and phentolamine that were either given or not a single dose of atropine were subjected to bilateral vagus nerve stimulation (30 min: 0.7 mA, 20 Hz, 0.2 ms). VIP concentrations in the atria were determined after each stimulation protocol. In control rats with or without single atropine administration, the heart rate upon vagal stimulation was higher than in atropinised animals with or without single atropine dose, respectively. VIP concentrations in the control atria were significantly decreased after the stimulation; the decrease was comparable both in the absence and presence of a single dose of atropine. Compared to controls, VIP levels were significantly decreased after chronic atropine treatment and they were not further reduced by vagal stimulation and single atropine administration. Administration of VIP antagonist completely abolished the differences in the heart rate upon vagal stimulation between control and atropinised groups. In conclusion, the data indicate that chronic atropine administration affects VIP synthesis in rat heart atria and consequently it modifies the heart rate regulation.

Citace poskytuje Crossref.org

Bibliografie atd.

Lit.: 51

000      
00000naa 2200000 a 4500
001      
bmc10015736
003      
CZ-PrNML
005      
20111210180555.0
008      
100726s2008 xr e eng||
009      
AR
024    7_
$a 10.33549/physiolres.931350 $2 doi
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kuncová, Jitka, $d 1964- $7 xx0078884
245    10
$a Chronic atropine administration diminishes the contribution of vasoactive intestinal polypeptide to heart rate regulation / $c J. Kuncová, Š. Faitová, J. Capouch, M. Štengl, J. Slavíková
314    __
$a Department of Physiology, Charles University, Plzeň, Czech Republic
504    __
$a Lit.: 51
520    9_
$a Vasoactive intestinal polypeptide (VIP) is implicated in the modulation of vagal effects on the heart rate. In this study, the impact of acute and chronic atropine administration on VIP levels in rat heart atria was investigated in relation to heart rate in the course of vagus nerves stimulation. Anaesthetised control and atropinised (10 mg/kg/day for 10 days) rats pretreated with metipranolol and phentolamine that were either given or not a single dose of atropine were subjected to bilateral vagus nerve stimulation (30 min: 0.7 mA, 20 Hz, 0.2 ms). VIP concentrations in the atria were determined after each stimulation protocol. In control rats with or without single atropine administration, the heart rate upon vagal stimulation was higher than in atropinised animals with or without single atropine dose, respectively. VIP concentrations in the control atria were significantly decreased after the stimulation; the decrease was comparable both in the absence and presence of a single dose of atropine. Compared to controls, VIP levels were significantly decreased after chronic atropine treatment and they were not further reduced by vagal stimulation and single atropine administration. Administration of VIP antagonist completely abolished the differences in the heart rate upon vagal stimulation between control and atropinised groups. In conclusion, the data indicate that chronic atropine administration affects VIP synthesis in rat heart atria and consequently it modifies the heart rate regulation.
650    _2
$a financování organizované $7 D005381
650    _2
$a alfa blokátory $x farmakologie $7 D000317
650    _2
$a beta blokátory $x farmakologie $7 D000319
650    _2
$a zvířata $7 D000818
650    _2
$a atropin $x aplikace a dávkování $7 D001285
650    _2
$a elektrická stimulace $7 D004558
650    _2
$a srdeční síně $x inervace $x metabolismus $7 D006325
650    _2
$a srdeční frekvence $x účinky léků $7 D006339
650    _2
$a antagonisté hormonů $x farmakologie $7 D006727
650    _2
$a metipranolol $x farmakologie $7 D014290
650    _2
$a antagonisté muskarinových receptorů $x aplikace a dávkování $7 D018727
650    _2
$a fentolamin $x farmakologie $7 D010646
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a receptory muskarinové $x metabolismus $x účinky léků $7 D011976
650    _2
$a časové faktory $7 D013997
650    _2
$a nervus vagus $x metabolismus $x účinky léků $7 D014630
650    _2
$a vazoaktivní intestinální peptid $x antagonisté a inhibitory $x farmakologie $x metabolismus $7 D014660
653    00
$a Vasoactive intestinal polypeptide
653    00
$a Atropine
653    00
$a Heart atria
653    00
$a Vagus nerve stimulation
653    00
$a Rat
700    1_
$a Faitová, Š. $7 _AN029710
700    1_
$a Capouch, J. $7 _AN029711
700    1_
$a Štengl, Milan, $d 1969- $7 xx0078886
700    1_
$a Slavíková, Jana, $d 1944- $7 jn20000710541
773    0_
$w MED00003824 $t Physiological research $g Roč. 57, č. 6 (2008), s. 827-837 $x 0862-8408
856    41
$u http://www.biomed.cas.cz/physiolres/pdf/57/57_827.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 4120 $c 266 $y 8
990    __
$a 20100708110758 $b ABA008
991    __
$a 20100806112716 $b ABA008
999    __
$a ok $b bmc $g 756151 $s 619934
BAS    __
$a 3
BMC    __
$a 2008 $b 57 $c 6 $m Physiological research $x MED00003824 $d 827-837
LZP    __
$a 2010-32/vtme

Najít záznam

Citační ukazatele